Nanjing Well Pharmaceutical Group Co.,Ltd.
SSE:603351.SS
28.73 (CNY) • At close June 10, 2025
Overview | Financials
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operationele Activiteiten: | |||||||||||
| Nettowinst
| 145.206 | 109.115 | 94.432 | 100.149 | 100.447 | 128.108 | 111.814 | 107.435 | 73.71 | 60.728 | 44.828 |
| Afschrijvingen & Amortisatie
| 116.065 | 71.736 | 71.758 | 42.809 | 34.343 | 34.059 | 27.942 | 25.528 | 21.103 | 17.444 | 0 |
| Uitgestelde Inkomstenbelasting
| 0 | -3.718 | 0.147 | -15.437 | 0.505 | 8.505 | 2.818 | 0.414 | -1.068 | -0.121 | 0 |
| Aandelen Gebaseerde Vergoedingen
| 0 | 0 | 28.063 | 15.437 | 0 | 0 | 0 | 0 | 13.954 | 0 | 0 |
| Verandering in Werkkapitaal
| -58.011 | -88.471 | -94.899 | -180.525 | -38.955 | -36.441 | -82.511 | -66.787 | -6.087 | -7.239 | 0 |
| Vorderingen
| -13.566 | -31.413 | 34.167 | -105.724 | 71.338 | -34.796 | -67.727 | -23.003 | -1.15 | -18.572 | 0 |
| Voorraden
| -40.462 | -9.382 | -22.766 | -29.179 | -0.552 | -14.72 | -6.511 | -29.992 | -1.187 | -2.349 | 0 |
| Crediteuren
| 0 | -43.957 | -106.447 | -42.057 | -110.245 | 4.57 | -11.091 | -14.206 | -2.682 | 13.802 | 0 |
| Overig Werkkapitaal
| -3.983 | -3.718 | 0.147 | -3.566 | 0.505 | 8.505 | -76 | -36.795 | -4.9 | -4.89 | 0 |
| Overige Niet-Contante Posten
| 18.533 | 31.581 | 9.487 | 26.031 | -2.531 | 3.968 | 6.513 | 5.095 | 39.455 | 10.203 | -44.828 |
| Kasstroom uit Operationele Activiteiten
| 221.793 | 120.244 | 108.989 | -11.537 | 93.304 | 129.694 | 63.758 | 71.271 | 128.181 | 81.136 | 74.615 |
| Investeringsactiviteiten: | |||||||||||
| Investeringen in Materiële Vaste Activa
| -51.458 | -73.071 | -233.902 | -235.62 | -282.439 | -120.615 | -76.95 | -63.351 | -69.309 | -76.917 | -88.541 |
| Netto Overnames
| 0 | 0 | 0 | 3.93 | -1,181.373 | 0.085 | 0.004 | 0.032 | 0.008 | 0.096 | 0 |
| Aankoop van Beleggingen
| -27.8 | -1 | -35 | -45 | -40 | -40 | 0 | 0 | -1.52 | -1 | 0 |
| Verkoop/verval van Beleggingen
| 9.477 | 6.228 | 31.224 | 217.721 | 1,181.373 | 530.732 | 0 | 0 | 0.1 | 1.004 | 0 |
| Overige Investeringsactiviteiten
| -0.7 | -0 | -3.776 | -8.996 | 157.004 | -865.893 | 0.518 | 0.601 | 0.918 | 4.5 | -0.004 |
| Kasstroom uit Investeringsactiviteiten
| -70.481 | -67.843 | -237.679 | -67.966 | -165.435 | -495.692 | -76.432 | -62.75 | -69.803 | -72.317 | -88.545 |
| Financieringsactiviteiten: | |||||||||||
| Schuldaflossingen
| 2.72 | 57.73 | 219.411 | 65.346 | 14.133 | 7.219 | 0 | 0 | -53 | 7.5 | 16 |
| Uitgifte van Gewone Aandelen
| 0 | 0 | 0 | 49.272 | 0 | 0 | -3.62 | 0 | 0 | 0 | 0 |
| Terugkoop van Gewone Aandelen
| 0 | 0 | 0 | -49.272 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Uitgekeerde Dividenden
| -55.467 | -53.415 | -40.644 | -39.2 | -42 | -40 | -30 | -21.416 | -52.136 | -14.057 | -13.46 |
| Overige Financieringsactiviteiten
| -10.285 | 0.476 | -17.572 | 50.467 | -4.734 | 546.573 | 8.987 | 18.308 | 101.142 | -0.296 | -0.007 |
| Kasstroom uit Financieringsactiviteiten
| -63.032 | 4.791 | 161.195 | 70.562 | -32.602 | 508.908 | -24.633 | -3.108 | -3.995 | -6.853 | 2.532 |
| Overige Informatie: | |||||||||||
| Effect van Wisselkoersveranderingen op Kas
| 1.373 | 0.527 | 1.059 | -0.355 | -0.641 | 0.432 | -0.391 | -1.217 | 0.975 | 0.04 | -0.007 |
| Netto Kasstroomverandering
| 89.654 | 57.719 | 33.565 | -9.296 | -105.374 | 143.342 | -37.698 | 4.196 | 55.359 | 2.006 | -11.404 |
| Kaspositie aan het Einde van de Periode
| 247.2 | 157.546 | 99.828 | 66.263 | 75.559 | 180.932 | 37.59 | 75.288 | 71.092 | 15.733 | 13.726 |